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V-ATPaseLactoferrin (Lf) is a bioactivemilk-derived proteinwith remarkablewide-spectrumantifungal activity. To deepen
our understanding of the molecular mechanisms underlying Lf cytotoxicity, the role of plasma membrane
ergosterol- and sphingolipid-rich lipid rafts and their association with the proton pump Pma1p was explored.
Pma1p was previously identified as a Lf-binding protein. Results showed that bovine Lf (bLf) perturbs
ergosterol-rich lipid rafts organization by inducing intracellular accumulation of ergosterol. Using yeast mutant
strains lacking lipid rafts-associated proteins or enzymes involved in the synthesis of ergosterol and
sphingolipids, we found that perturbations in the composition of these membrane domains increase resistance
to bLf-induced yeast cell death. Also, when Pma1p-lipid rafts association is compromised in the Pma1–10mutant
and in the absence of the Pma1p-binding protein Ast1p, the bLf killing activity is impaired. Altogether, results
showed that the perturbation of lipid rafts and the inhibition of both Pma1p and V-ATPase activities mediate
the antifungal activity of bLf. Since it is suggested that the combination of conventional antifungals with lipid
rafts-disrupting compounds is a powerful antifungal approach, our data will help to pave the way for the use
of bLf alone or in combination for the treatment/eradication of clinically and agronomically relevant yeast path-
ogens/fungi.
© 2021 Elsevier B.V. All rights reserved.1. Introduction
Lactoferrin (Lf), a glycoprotein with ca. 80 kDa, is one of the most
well-known milk bioactive proteins. Besides in milk, it is present in
many different biological fluids of mammalian species including muco-
sal surfaces, saliva and tears [1]. Multiple biological activities have been
attributed to this protein since itwasfirst identified in bovinemilkmore
than 80 years ago [2], such as anticancer and antimicrobial [3], including
antifungal activity against different species of both yeasts and molds.
The mechanisms underlying the Lf antifungal activity described so
far generally rely on its ability to sequester iron, to interact with the
cell surface and to induce cell death [4]. In fact, we previously found
that human Lf (hLf) induces an apoptotic-like cell death process in theiversity of Minho, Campus de
eal).yeasts Candida albicans [5] and Saccharomyces cerevisiae [6], which is as-
sociated with nuclear chromatin condensation, increased production of
reactive oxygen species and mitochondrial dysfunctions. Furthermore,
we identified the plasma membrane proton pump Pma1p as a hLf-
binding protein [7]. Pma1p is a P-type H+-ATPase that mediates proton
extrusion powered by ATP hydrolysis to maintain pH homeostasis, ion
balance and nutrient uptake in plant cells and fungi [8]. By binding
and inhibiting Pma1p activity, hLf leads to increased intracellular ATP
levels, perturbation of cytosolic pH and ion homeostasis and, conse-
quently, lethal mitochondrial dysfunction [7,9].
Pma1p is localized at specific nanodomains of the plasmamembrane
called lipid rafts [10,11]. These are highly organized and tightly packed
structures rich in ergosterol and sphingolipids that function as plat-
forms for signalling and protein trafficking. They are generally identified
as detergent-resistant membranes (DRMs) after cell fractioning with
non-ionic detergents [11]. Lipid rafts affect the mechanical properties
of the plasma membrane and are involved in fungal pathogenicity and
biofilm formation [65]. Moreover, since lipid rafts are involved in the
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they have been implicated in drug resistance. Several antifungal pep-
tides can target lipid rafts, affecting their integrity and the function of
these pumps, which allows them to overcomedrug resistance and to in-
duce cell death [13,14]. Thus, the combination of antifungal peptides
targeting lipid rafts with conventional antifungal drugs has been sug-
gested as a powerful antifungal strategy [15].
Different reports have supported the importance of lipid rafts for
Pma1p activity. Indeed, lipid raft association is crucial for proper surface
targeting and Pma1p stability at the plasma membrane [16]. Thus, dis-
ruption of lipid rafts leads to mistargeting of Pma1p to the vacuole
[17]. Sphingolipids, which are critical and abundant in lipid rafts, are
also required for Pma1p oligomerization at the ER, its targeting to the
plasma membrane, and its stability at the cell surface [18,19].
Given this interplay and interdependence between Pma1p and lipid
rafts, and because Lf binds and inhibits this proton pump, in the present
study we aimed to uncover the role of lipid rafts in bovine Lf (bLf)-in-
duced cell death, and to explore the bLf-Pma1p-lipid rafts axis. Human
and bovine Lfs share a high degree of sequence identity (69%) [20], a
similar structure [21] and function/activity against fungi [22]. The effect
of lipid raft composition on bLf cytotoxicitywas studied using yeastmu-
tant strains lacking lipid rafts-associated proteins or enzymes that me-
diate the synthesis of ergosterol and sphingolipids, the major
components of DRMs. The Rvs161p (encoded by RVS161/END6 gene)
is a protein localized in lipid rafts [23]. The ERG6 gene encodes the sterol
C-24 methyltransferase that catalyses the final steps of ergosterol bio-
synthesis by converting zymosterol to fecosterol (Fig. 1A). Therefore,
erg6Δ mutants accumulate mainly zymosterol and cholesta-5,7,24-
trienol instead of ergosterol [24]. The other two genes under study are
involved in the sphingolipid metabolism (Fig. 1B). LAC1 encodes a com-
ponent of ceramide synthase, which is involved in de novo synthesis of
ceramide by N-acylation of sphingoid bases. The ISC1 gene encodes the
mitochondrial inositol phosphosphingolipid phospholipase C that is in-
volved in the synthesis of ceramide by hydrolysis of complex
sphingolipids (Fig. 1B) [25].Fig. 1. Ergosterol (A) and sphingolipid (B) biosynthetic pathways in Saccharomyces cerevisiae. Fo
were deleted to construct the mutant strains used in this work are marked in red with an aste
referred to the web version of this article.)
3442. Materials and methods
2.1. Strains and plasmids
All S. cerevisiae strains and plasmids used in this study are listed in
Table 1. BY4741 and L3852 were used as wild type strains. BY4741,
erg6Δ, rvs161Δ, lac1Δ, isc1Δ and ast1Δ strains were transformed with
the pRS316 Pma1-GFP using the LiAc/SS Carrier DNA/PEG method
[26]. The ast1Δ strain was transformed with the high copy pAC49
AST1 plasmid using the same method. The XGY32 strain harbours the
pma1–10 mutations and it was produced by pop-in pop-out gene re-
placement of the PMA1 gene [16].
2.2. Growth conditions
All strains were grown in YEPD (yeast extract-peptone-dextrose)
medium [1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose],
with the exception of the strains expressing plasmids that were grown
in Synthetic Complete Glucose medium [SC Glu pH 5.5; 2% (w/v) glu-
cose; 0.67% (w/v) yeast nitrogen base without amino acids and ammo-
nium sulphate; 0.5% (w/v) ammonium sulphate; 0.1% (w/v) potassium
phosphate, 0.2% (w/v) drop-out mixture lacking histidine, leucine, tryp-
tophan and uracil; 0.01% (w/v) histidine, 0.02% (w/v) leucine and 0.01%
(w/v) tryptophan]. The yeast strains were grown at 30 °C in an orbital
shaker at 200 rpm, with a ratio of flask volume/medium of 5:1 until
reaching the exponential phase (OD640 = 0.6–0.8).
2.3. Lactoferrin treatment and cell survival assays
After reaching the exponential phase, yeast cells were harvested, re-
suspended in 10 mM Tris-HCl buffer pH 7.4 [6] and incubated with
0–1500 μg/ml bLf and/or with 20 μM C2-ceramide (N-Acetyl-D-sphin-
gosine, Sigma-Aldrich) or its solvent (absolute ethanol) for 90 min
under the same aforementioned growth conditions (and/or at 37 °C inr ergosterol, only the last steps of the biosynthetic pathway are represented. The genes that
risk (*). (For interpretation of the references to colour in this figure legend, the reader is
Table 1
List of S. cerevisiae strains and plasmids used.
Strain Genotype Reference/source
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Euroscarf
erg6Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
erg6Δ::KanMX4
Euroscarf
rvs161Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
rvs161Δ::KanMX4
Euroscarf
lac1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
lac1Δ::KanMX4
Euroscarf
isc1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
isc1Δ::KanMX4
Euroscarf
ast1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
ast1Δ::KanMX4
Euroscarf
BY4741 PMA1-GFP BY4741 harbouring pRS316 PMA1-GFP This study
erg6Δ PMA1-GFP erg6Δ harbouring pRS316 PMA1-GFP This study
rvs161Δ PMA1-GFP rvs161Δ harbouring pRS316
PMA1-GFP
This study
lac1Δ PMA1-GFP lac1Δ harbouring pRS316 PMA1-GFP This study
isc1Δ PMA1-GFP isc1Δ harbouring pRS316 PMA1-GFP This study
ast1Δ PMA1-GFP ast1Δ harbouring pRS316 PMA1-GFP This study
ast1Δ AST1 ast1Δ harbouring pAC49-AST1 This study
L3852 MATa his3Δ200 lys2Δ201 leu2–3112
ura3–52 ade2
[43]




pRS316 PMA1-GFP PMA1 gene fused with the yeast GFP3
gene, URA3
[23]
pAC49-AST1 AST1 URA3 2 μ [43]
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employed in the experiments with isolated plasma membranes
(15 min) and vacuoles (right before ATP addition) as well as with bLf-
FITC (75 min). bLf was obtained from DMV (Veghel, The Netherlands).
The protein is ca. 80% pure, with 3.5% moisture, and 21% iron-
saturated, according to the manufacturer. bLf was dissolved in sterile
distilled water (dH2O) to obtain the different concentrations used
throughout this work.
Cell survival was evaluated by counting of colony forming units (c.f.
u.). Briefly, four serial dilutions of the cultures were performed, and the
10−4 dilution was plated onto YEPD containing 2% (w/v) agar and incu-
bated for 48 h at 30 °C. The percentage of cell survival was calculated
from the number of c.f.u. of each condition in relation to time zero and
the control without any treatment.
2.4. Filipin staining, PMA1-GFP localization and fluorescence microscopy
For visualization of sterol-rich lipid rafts, yeast cells were stained
with filipin (Filipin III from Streptomyces filipinensis, Sigma), a naturally
fluorescent antibiotic widely used to visualize sterols [27]. After treat-
ment with or without bLf, cells were collected at an OD640 = 0.5 and
concentrated 20× in sterile water. Immediately before visualization
under the fluorescence microscope, cells were incubated for 1 min in
the dark with 0.1 mg/ml filipin from a stock solution of 5 mg/ml (w/v)
in methanol [28]. Cells were then mounted on slides with the anti-
fading agentVectashield (Vector Laboratories) to overcome the instabil-
ity of this dye, and then visualized in an epifluorescence microscope. As
a positive control of lipid rafts disruption, cells were treated for 30 min
at 30 °C in an orbital shaker at 200 rpm with 5 mg/ml methyl-β-cyclo-
dextrin (MβCD) in 10 mM Tris-HCl buffer pH 7.4.
For determination of Pma1p localization, PMA1-GFP expressing cells
without any treatment were grown until early-exponential phase, col-
lected by centrifugation at 3000×g for 3min, and resuspended in sterile
water at an OD640 = 10. Samples were observed under the fluores-
cence microscope immediately. The percentage of cells with altered
Pma1p localization was calculated by counting the number of cells
with normal and altered Pma1p localization in each observed field.
More than 800 cells were counted.345The imageswere obtained in thefluorescencemicroscope (Leica DM
5000B, Leica Microsystems) with appropriate filter settings using a
100× oil-immersion objective with a Leica DCF350FX digital camera,
and processed with LAS Leica Microsystems software.
2.5. Lactoferrin-FITC labelling
For labelling of bLf with fluorescein-5-isothiocyanate (FITC), 50 μg/
ml of FITC (Sigma-Aldrich) were added to a solution of 18,13 mg/ml of
bLf in 1 M sodium bicarbonate buffer pH = 9 and incubated for 2 h in
the dark with agitation. Afterwards, the unbound FITC was removed
by several spin-separation cycles at 6000 × g for 5 min using Amicon
Ultra-0.5, Ultracel-30 Membrane (30 kDa cutoff), and finally buffer ex-
change to water was performed using the same approach. A control
with only FITC was performed and added to cells. No fluorescence was
detected using the same settings as those for bLf-FITC.
2.6. Assessment of metabolic activity by FUN-1 staining
Metabolic activity of yeast cells was evaluated by Fun-1 [(2-chloro-
4-(2,3-dihydro-3-methyl-(benzo-1,3-thiazol-2-yl)-methylidene)-1-
phenylquinolinium Iodide), Molecular Probes] staining. Fun-1 is a
membrane-permeant dye that is transported to the vacuole and
compacted into cylindrical intravacuolar structures (CIVS) only in met-
abolically active yeast cells [29]. After 90 min incubation in the absence
or presence of 425 μg/ml bLf, 1 ml of cells at OD640 = 0.1 were har-
vested, resuspended in phosphate buffered saline (PBS) 1× (PBS 10×;
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7)
and stained with 4 μM FUN-1 for 30 min at 30 °C in the dark. 5 min-
boiled wild type cells were used as a positive control for defective met-
abolic activity. Stained cell suspensions were then analysed in an
epifluorescence microscope and in a flow cytometer. Flow cytometry
data are presented as the mean FL4 fluorescence intensity in relation
to the autofluorescence of each sample and untreated cells of each
strain.
2.7. Analysis of glucose-dependent extracellular acidification
Extracellular acidification rate was estimated as previously de-
scribed [7]. Briefly, after growth and treatment without or with
0–1500 μg/ml bLf or 100 μM diethylstilbestrol (DES) as reported for
cell survival assays, cells were washed once with 50 mM KCl and then
resuspended and concentrated (107 cells/ml) in 1 ml of 50 mM KCl
and subjected to pH measurements. After pH stabilization, 2.5 mM glu-
cose was added and acidification was measured every minute for
12 min using a pH meter with constant stirring. A sample was taken
from each condition to estimate the dry weight after incubation at
80 °C for two days. Data is presented as ΔpH/min/mg dry weight.
2.8. Plasma membrane isolation
Plasmamembranes were obtained as described previously [7], with
somemodifications. Briefly, 4 l of yeast culturewere grown inYEPDme-
diumuntil late-log phase. Cells were then harvested, washed twicewith
distilled sterilewater and resuspended in homogenization buffer [2mM
EDTA, 2% (w/v) glucose, 1 mM phenylmethylsulfonyl fluoride (PMSF),
0.2 ng/ml DNase, 50 mM Tris pH 7.4]. Whole cells were then disrupted
by three passages at 19,500 lb./in2 in a French pressure cell (SLM
Aminco, Silver Spring, MD). The resulting cell suspension was centri-
fuged at 3000 ×g 4 °C for 10 min to remove cell debris and unbroken
cells, and the supernatant was centrifuged twice at 14000 ×g 4 °C for
30 min. Afterwards, the homogenate was centrifuged at 100000 ×g
4 °C for 1 h 30min and the pellet containing the cell membraneswas re-
suspended in ice-cold resuspension buffer [0.5 mM EDTA, 20% (v/v)
glycerol, 0.1 mM PMSF, 10 mM Tris pH = 7.4]. Protein concentration
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−80 °C.
2.9. Measurement of ATP hydrolysis
ATP hydrolysis assay was performed using the PiColorLock™ Gold
Phosphate Detection kit (obtained from Innova Biosciences, Ltd. Cam-
bridge, UK), which allows the quantification of the inorganic phosphate
(Pi) concentration, according to the manufacturer's instructions. For all
experiments, a calibration curve with a standard range of Pi concentra-
tionswas performed.Measurementswere performed in isolated plasma
membranes at a concentration of 12.5 μg/ml in assay medium contain-
ing 0.2mMATP. To avoid interference of the activity of vacuolar andmi-
tochondrial ATPases and acid phosphatases, membranes were pre-
incubated for 15 min at 30 °C with 50 mM KNO3, 0.2 mM ammonium
molybdate and 5 mM sodium azide [31], respectively. Afterwards,
membrane extracts were incubated with 100 μg/ml bLf or 100 μM DES
for 15 min at 30 °C. DES was used as a positive control for Pma1p inhi-
bition [7]. Pi concentration was calculated by spectrophotometry at
620 nm.
2.10. Evaluation of intracellular ATP concentration
Intracellular ATP concentration was quantified using the BacTiter-
Glo™ Microbial Cell Viability kit as recommended. For all experiments,
a calibration curve with standard ATP concentrations (10–1000 nM)
was performed. Cells were grown as described for cell survival assays
and treated in the absence or presence of 250 and 425 μg/ml bLf and
100 μM DES for 90 min at 30 °C with 200 rpm agitation. 50 μl of each
condition were transferred to a 96-well opaque plate, mixed with
equal volume of BacTiter-Glo reagent and incubated for 15 min in the
dark. The emitted luminescence was read in a Varioskan flash multi-
mode reader (Thermo Scientific). The reagent uses a thermostable lucif-
erase that produces a luminescence signal proportional to the ATP
concentration. Data is shown in arbitrary units as fold change expressed
in relation to the untreated control of each strain (considered as 1).
2.11. Protein extraction and Western blot
For preparation of whole cell extracts, 1ml of exponentially growing
cells at OD640 = 1 were harvested by centrifugation at 5000 ×g for
3 min and washed once with dH2O. Cells were then resuspended in
500 μl water containing 50 μl lysis buffer 3.5% (v/v) β-
mercaptoethanol in 2 M NaOH) and incubated for 15 min on ice. Next,
50 μl of 50% trichloroacetic acid were added and incubated for addi-
tional 15 min to precipitate the proteins. The extracts were centrifuged
at 10000×g 10min 4 °C,washedwith acetone and centrifuged again. Fi-
nally, protein extracts were resuspended in Laemmli buffer (2% (v/v) β-
mercaptoethanol, 0.1 M Tris pH 8.8, 20% (v/v) glycerol, 0.02% (v/v)
bromophenol blue). Samples were heated at 95 °C and used immedi-
ately for Western blot or stored at−20 °C.
For detection of Pma1p expression levels, 50 μg of protein extracts
were separated by 10% sodium dodecyl sulfate - polyacrylamide gel
electrophoresis (SDS-PAGE) for 1 h. Proteins were then transferred
onto nitrocellulose membranes and membranes were blocked in 5%
non-fat milk in PBS-Tween 0.1% (v/v) solution (1× PBST) with agitation
at RT for 1 h to avoid non-specific interactions. Membranes were then
cut into strips and incubated overnight at 4 °Cwith theprimary antibod-
ies mouse monoclonal anti-yeast phosphoglycerate kinase (Pgk1p) an-
tibody (1∶5000, Molecular Probes) and mouse monoclonal antibody to
Pma1p (1:1000, 40B7, Invitrogen). Pgk1p was used as the loading con-
trol. Subsequently, membranes were incubated with the secondary an-
tibody Peroxidase-AffiniPure goat anti-mouse IgG (1:5000, Jackson
ImmunoResearch). Chemiluminescence detection was performed
using the ECL detection system (Millipore-Merck) in a ChemiDoc XRS
system (Bio-Rad).3462.12. Isolation of intact yeast vacuoles
Vacuole isolation was performed as previously described [32,33].
After grown until an OD640 = 0.7, 1 l of BY4741 cell suspension
was collected, washed twice with ice-cold distilled water,
resuspended in washing buffer [5% (w/v) glucose, 10 mM MES
(morpholineethanesulfonic acid)-Tris, pH 6.5] and incubated in a
shaker at 30 °C for 30min. Afterwards, cells were incubated with diges-
tion buffer [1.35 M sorbitol, 10 mM citric acid, 30 mM Na2HPO4, 1 mM
EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic
acid), 30mMDTT (dithiothreitol), pH 7.5] for 15min at room tempera-
ture. Spheroplasts were generated by subsequent incubation with
2mg/mL of zymolyase in digestion buffer without DTT, and cell wall di-
gestion wasmonitored in a phase contrast microscope. When digestion
was completed, spheroplastswere pelleted by centrifugation at 2750×g
for 5 min and washed with digestion buffer without DTT. They were
then resuspended in 12% (w/v) Ficoll and homogenized in a Potter-
Elvehjem to disrupt the cellmembrane. To isolate vacuoles by Ficoll gra-
dient centrifugation, the resulting homogenate was centrifuged at
2750 ×g for 3 min and the supernatant was recovered. The gradient
was prepared by carefully adding 8% (w/v) Ficoll on the top of the super-
natant. Ultracentrifugation was performed at 80000 ×g for 30 min in a
SW 28 Ti swinging-bucket rotor. The white fraction on top of the gradi-
ent containing highly purified vacuoles was collected and used in the
spectrofluorometric studies. Protein concentration was determined by
the Lowry method [34], using BSA (5 μg/μl–25 μg/μl) to build the stan-
dard curve.2.13. Measurement of V-ATPase activity by spectrofluorimetry
The pH-sensitive probe ACMA (9-amino-6-chloro-2-
methoxyacridine) was used to determine the proton-pumping activity
of V-ATPase in the isolated vacuoles using a Perkin-Elmer LS-5B spectro-
fluorimeter as previously reported [32,33,35]. 20 μg of isolated vacuoles
were added to a buffer containing 1 mM MOPS [3-(N-morpholino)
propanesulfonic acid]-Tris pH 7.2, 2 μM ACMA, 1 mM MgCl2 and
100 mM KCl. 4 or 80 μg/ml bLf were added to the assay medium at
steady-state to study their inhibitory effects. The reaction was started
by adding 0.1–0.5 mM ATP and the rate of initial fluorescence
quenching was recorded. The excitation/emission wavelengths were
set to 415nmand485 nm, respectively. The initial rate of ACMAfluores-
cence quenching was considered a measure of the V-ATPase proton
pumping activity [Δ%Fmin−1] and thefluorescence quenching recovery
as the inhibition of this activity. The results were analysed using the
GraphPad Prism Software and the proton pumping-kinetics best fitting
the experimental initial acidification curves, corresponding to the
quenching of ACMA fluorescence, were determined.2.14. Analysis of vacuolar pH variations using the carboxy-DCFDA probe
Vacuolar pH alterations were detected by both fluorescence
microscopy and flow cytometry using the 5-(and-6)-carboxy-2′,7′-
dichlorofluorescein diacetate (CDCFDA) probe. Untreated or bLf-
treated cells were harvested by centrifugation (1 mL OD640 = 0.1),
washed once with sterile water and resuspended in CF buffer [50 mM
glycine, 10 mM NaCl, 5 mM KCl, 1 mM MgCl2, 40 mM Tris, 100 mM
MES pH 4.5 supplemented with 2% (w/v) glucose] [36]. The cell suspen-
sion was then incubated with 1.6 μM CDCFDA for 20 min at 30 °C with
200 rpm orbital agitation. Afterwards, cells were washed once with CF
buffer without glucose, and finally resuspended in the same buffer for
further analysis in the flow cytometer or fluorescence microscope.
Flow cytometry data are presented as themean FL1 fluorescence inten-
sity in relation to the autofluorescence of each sample and untreated
cells of each strain.
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For immunoprecipitation, 10ml of yeast culture at OD640= 1were
collected and resuspended in a buffer containing 2 mM EGTA, 10 mM
Tris/Maleate pH 6.8 and a cocktail of protease inhibitors (cOmplete,
Roche). Mechanic lysis was then performed using glass beads and a
fast prep equipment, and supernatant was collected and centrifuged at
800 ×g for 10 min. 1 mg from the supernatant were solubilized in 1×
IP50 buffer (Sigma-Aldrich) 40 min at 4 °C and incubated overnight
with 1 μg of anti-Pma1 (40B7, Invitrogen) or anti-bLf (ab112968,
Abcam) antibodies. Protein G-sepharose beads (Sigma-Aldrich) were
then added and incubated for additional 4 h. Beads were washed 4
times with 1× IP50 buffer and two times with 0.1× IP50 buffer, and
ressuspended in 25 μl of Laemmli buffer 1×, before SDS-PAGE andWest-
ern blotting.
2.16. Flow cytometry
Flow cytometry analysis was performed with an Epics® XLTM
(Beckman Coulter) flow cytometer equipped with an argon-ion laser
emitting a 488 nm beam at 15 mW. Green fluorescence (CDCFDA)
was collected through a 488 nm blocking filter, a 550 nm long-pass di-
chroic and a 525nmband-passfilter. Redfluorescence (FUN-1)was col-
lected through a 560 nm short-pass dichroic, a 640 nm long-pass, and
another 670 nm long-pass filter. For each sample, 30,000 events were
evaluated. Data were analysed using the FlowJo software.
2.17. Statistical analysis
Data are expressed as the mean and standard deviation values of at
least three independent experiments. Statistical analyses were carried
out using the GraphPad Prism software, one-way or two-way ANOVA
and the Tukey post-test. P-values lower than 0.05 were considered to
represent a significant difference.
3. Results
3.1. bLf induces intracellular accumulation of ergosterol perturbing lipid
rafts of yeast cells
To ascertain whether ergosterol-rich lipid rafts play a role in Lf-
induced cytotoxicity in yeast, their cellular distribution was assessed.
Since sterols are major lipid rafts components, cellular ergosterol local-
ization was monitored using filipin staining after 90 min exposure to
250–425 μg/ml of bLf, which induces loss of cell viability of 70% - 98%,
respectively (Fig. 2A). As shown in Fig. 2B, the characteristic punctuated
pattern of the lipid rafts at the plasma membrane (head arrows) is
observed in control cells, while intracellular spots of filipin staining (ar-
rows) are visible in bLf-treated cells. Cell treatment with methyl-β-cy-
clodextrin (MβCD), a sterol chelator known to disrupt lipid rafts by
depleting ergosterol frommembranes [37], induced a similar intracellu-
lar filipin-staining pattern as bLf, confirming that bLf perturbs the nor-
mal ergosterol-rich lipid rafts distribution pattern by causing
intracellular accumulation of ergosterol.
3.2. Yeast mutants lacking lipid rafts-associated proteins or enzymes in-
volved in the synthesis of the lipid rafts major components are more resis-
tant to bLf-induced cytotoxicity
We next assessed the impact of perturbing lipid rafts composition
using yeast mutants lacking proteins that are either present at lipid
rafts or are involved in pathways that lead to the synthesis of their
major lipid components, ergosterol and sphingolipids, namely
rvs161Δ, erg6Δ, lac1Δ and isc1Δmutants (see Introduction section). Re-
sults showed that absence of these proteins greatly increases the resis-
tance of themutant cells to bLf-induced cytotoxicity in comparisonwith347the wild type strain (Fig. 3A). Remarkably, even at 500 μg/ml bLf, which
is highly toxic for the wild type strain (only about 2% cell survival), the
mutants affected in sphingolipid metabolism exhibit about 23% of cell
survival.
Our data further indicates that themetabolic activity of thewild type
strain is affected by the bLf treatment using FUN-1 staining (Fig. 3B, C).
FUN-1 is a membrane-permeant dye that is first detected as diffuse
green fluorescence in the cytosol before its accumulation in the vacuole
of metabolically active yeast cells forming red cylindrical intravacuolar
structures (CIVS), as observed in Fig. 3B (red spots) [38]. The treatment
of yeast cells with bLf produced a diffuse brightfluorescence, suggesting
that the cells became metabolically inactive (Fig. 3B) as they were not
able to process the dye at the vacuole, much like heat-killed cells
[29,39]. Accordingly, flow cytometry analysis of wild type cells stained
with FUN-1 showed that the red mean fluorescence intensity increased
2-fold from control to bLf-treated cells, while no differences in fluores-
cence intensity were observed in the mutant strains (Fig. 3C), in agree-
ment with their higher resistance to bLf.
3.3. bLf does not alter localization of ergosterol-rich lipid rafts in rvs161Δ,
erg6Δ, lac1Δ and isc1Δ mutants
As the cytotoxicity of bLf in the wild type strain was associated with
intracellular accumulation of ergosterol and perturbation of lipid rafts,
the mutants under study were stained with filipin in the presence and
absence of bLf. Results showed that bLf only affected ergosterol distribu-
tion in the wild type strain, showing no effect on the mutants, which is
in agreement with their higher survival rate upon treatment with bLf
(Fig. 4A, B).
3.4. Inhibition of Pma1p proton pumping and hydrolytic activities by bLf is
prevented in rvs161Δ, erg6Δ, lac1Δ and isc1Δ mutants
We next sought to test the hypothesis that the higher resistance of
themutants is due to the lack of sensitivity of their Pma1p to bLf inhibi-
tion. As shown in Fig. 5A, the Pma1p of wild type cells was inhibited by
bLf in a time- and concentration-dependent manner, much like it was
previously observed in the pathogenic yeast C. albicans [7]. Diethylstil-
bestrol (DES) was used as a positive control of Pma1p inhibition [7].
Whenwild type cells were incubatedwith fluorescein-5-isothiocyanate
(FITC)-labelled bLf, a punctuated pattern was observed at the plasma
membrane (Fig. 5B), suggesting that bLf binds to Pma1p, as further con-
firmed by immunoprecipitation (Fig. 5F). Contrarily to the result ob-
tained in the wild type cells, bLf failed to inhibit Pma1p proton
pumping activity of the mutant strains rvs161Δ, erg6Δ, lac1Δ and
isc1Δ, as indicated by the unperturbed extracellular acidification rates
(Fig. 5C). Accordingly, when the hydrolytic activity of Pma1p was mea-
sured, the inhibitory effect of bLf over Pi release was much less pro-
nounced in plasma membrane fractions isolated from the mutant
strains than from wild type cells (Fig. 5D). In agreement, incubation of
intact cells with bLf led to an increase in intracellular accumulation of
ATP in thewild type strain but not in themutant strains (Fig. 5E). Immu-
noprecipitation experiments revealed that, although Pma1p activity is
not affected by bLf in themutant strains, bLf is still able to bind the pro-
ton pump (Fig. 5F, G).
To determinewhether these phenotypes could be related to intrinsic
differences in Pma1p activity/localization in the mutant strains under
study, all strains were transformed with a pRS316 PMA1MA-GFP plas-
mid and stainedwith filipin to visualize lipid rafts. Fluorescencemicros-
copy showed that PMA1MA-GFP co-localizes at the plasma membrane
with lipid rafts in all strains (Fig. 6A). Additionally, immunodetection
of Pma1p by Western blot demonstrated that the expression levels of
this proton pump are similar in all strains (Fig. 6B, C). Moreover,
Pma1p activity of the mutant strains, expressed by the extracellular
acidification rate, is similar to the wild type thus demonstrating that
Pma1p is functional (Fig. 6D).
Fig. 2. Effect of bLf on the localization of ergosterol-rich lipid rafts in S. cerevisiae BY4741 cells. Cells were incubated in the absence or presence of increasing concentrations of bLf
(125–500 μg/ml) for 90 min at 30 °C in Tris-HCl 10 mM, pH 7.4. (A) Cell survival was assessed by counting colony forming units. (B) For lipid rafts visualization, cells were stained in
the dark with 0.1 mg/ml filipin immediately before visualization under the microscope. As a positive control of lipid rafts disruption, cells were treated with 5 mg/ml methyl-β-
cyclodextrin (MβCD) for 30 min. Representative fluorescence microscopy images of each condition are shown. Arrows: intracellular filipin staining. Head arrows: plasma membrane
filipin staining. Bar: 5 μm.
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erg6Δ, lac1Δ and isc1Δ mutants
Given that bLf inhibits Pma1p activity likely perturbing the intracel-
lular pH homeostasis,we sought to test its effect on the vacuolar pH. The
pH-sensitive probe 5-(and-6)-carboxy-2,7-dichlorofluorescein
diacetate (CDCFDA) is cleaved by intracellular esterases, and the
unsterified pH-sensitive form (CDCF) accumulates in the yeast vacuole
exhibiting higher fluorescence at higher pH values [36,41]. Results
showed that when wild type yeast cells were labelled with this pH-
sensitive probe a higher fluorescence signal was observed in bLf-
treated than in untreated cells by both fluorescence microscopy
(Fig. 7A, white arrows) and flow cytometry (Fig. 7B). On contrary, bLf
did not induce vacuolar alkalinisation in the mutant cells (Fig. 7B).348Following our previous reports showing that bLf targets and inhibits
V-ATPase activity in cancer cells [35,42], the present results suggest
that V-ATPase can be inhibited by bLf in wild type yeast cells but not
in mutant cells. Accordingly, results depicted in Fig. 7C showed for the
first time that bLf inhibits the yeast V-ATPase proton pumping activity
in a concentration-dependentmanner in purified vacuolar fractions iso-
lated from the wild type strain.
3.6. Disruption of Pma1p-lipid rafts association induced by Pma1p point
mutations or AST1 deletion renders yeast cells resistant to bLf
To get further insights on the role of Pma1p localization at the lipid
rafts for bLf-induced cytotoxicity, we next explored the effect of bLf on
a strain harbouring Pma1p point mutations that alter its localization
Fig. 3. Effect of bLf on cell survival and metabolic activity of wild type and rvs161Δ, erg6Δ, lac1Δ and isc1Δ mutant strains. (A) Cell survival assays of S. cerevisiaewild type BY4741 and
indicated mutant strains 90 min after incubation with 0–500 μg/ml bLf in 10 mM Tris-HCl, pH 7.4, at 30 °C, evaluated by colony forming unit counting. Values are mean ± standard
deviation normalized to time zero of incubation and considering the control without bLf as 100% cell survival. (B) Fluorescence microscopy images showing FUN-1 staining of BY4741
wild type cells non-treated (control) or treated with 425 μg/ml bLf. (C) Flow cytometry analysis of FUN-1 staining of the same yeast strains treated as in A without or with 425 μg/ml
bLf. 5 min-boiled cells were used as a control of metabolically inactive dead cells (C+). Values represent mean ± standard deviation of red (FL4) fluorescence intensity normalized to
autofluorescence of each sample and control of each strain. ns, non-significant; *, **, *** P < 0.05, 0.01, 0.001, respectively, in comparison with the control of each strain; #, ####
P < 0.05, 0.0001, respectively, in comparison with the wild type strain. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of
this article.)
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Fig. 4.Effect of bLf on the localization of ergosterol-rich lipid rafts ofwild type and rvs161Δ, erg6Δ, lac1Δ and isc1Δmutant strains. Cellswere incubated in the absence (control) or presence
of increasing concentrations of bLf (250–425 μg/ml) for 90min at 30 °C in Tris-HCl 10mMpH7.4 buffer. (A) For lipid rafts visualization, cellswere stained in the darkwith 0.1mg/mlfilipin
immediately before visualization under the microscope. Representative fluorescence microscopy images of each condition are shown. Although erg6Δ cells do not synthetize ergosterol,
they are still labelledwith filipin as previously reported [40], because it also binds sterol intermediates. (B) Quantification of the percentage of cells with altered lipid rafts distribution. At
least 300 cells per condition of three independent experiments were counted. *** P < 0.001 in comparison with the control of each strain.
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A165G and V197Imutations, both at the first cytoplasmic loop between
transmembrane segments 2 and3 of Pma1p. In thismutant strain, at the
restrictive temperature of 37 °C, newly synthesized Pma1–10 fails to as-
sociate with the plasma membrane lipid rafts (Triton-insoluble frac-
tion) and is delivered to the vacuole for degradation [16]. Results from
cell survival assays showed that the Pma1–10 expressing cells are
more resistant to 75 μg/ml bLf at both 30 °C and 37 °C than the L3852
wild type strain, but the difference is more evident at 37 °C (Fig. 8A).
In this experiment, a lower bLf concentration was used because the
wild type strain is more sensitive to bLf than the BY4741 strain.
Ast1p is a Pma1p-binding protein known to be involved in the deliv-
ery of Pma1p to the cell surface and its associationwith lipid rafts.When
multicopy AST1 is expressed inmutated Pma1p cells, Pma1p is rerouted
to the cell surface and associates with lipid rafts [17,43]. Results showed
that the deletion of AST1 gene renders cells more resistant to bLf, sug-
gesting that its function in promoting the association of Pma1p with
lipid rafts is critical for the bLf cytotoxicity (Fig. 8B). Accordingly,
when multicopy AST1 is expressed in this background, cells become
sensitive to bLf again, thus demonstrating that the resistance is indeed
related with AST1 deletion, and not with other possible pleiotropic ef-
fects (Fig. 8B). When PMA1-GFP was expressed in ast1Δ cells, about
30% of the cells exhibited bright intracellular spots of PMA1-GFP
(Fig. 8C, D), proposing an abnormal Pma1p localization in this strain.350In agreement with the previous results, the absence of Ast1p causes
an abnormal intracellular localization of both ergosterol-rich lipid rafts
and PMA1-GFP (Fig. 8E), which is consistent with the role of Ast1p in
Pma1p-lipid rafts association.
4. Discussion
It has been reported that the milk-derived protein Lf displays anti-
fungal activity against different yeast species [44], including C. albicans
[5] and S. cerevisiae [6], as well as against different fungi isolated from
plants and soils, including Aspergillus niger and Rhizoctonia solani [45].
Given its potential to become a wide-spectrum antifungal, herein we
sought to deepen our understanding of the mechanisms underlying Lf
cytotoxic activity using S. cerevisiae as a model. As previously shown
inC. albicans [7,9],we found that bLf binds to Pma1p and inhibits its pro-
ton pumping and hydrolytic activities associatedwith an increase of the
intracellular ATP levels. Because lipid rafts are important for cell surface
sorting, stability and oligomerization of Pma1p [17],we investigated the
effect of bLf in these ergosterol- and sphingolipid-rich membrane mi-
crodomains. Our data revealed a novel mode of action of bLf against
yeast by inducing intracellular accumulation of ergosterol and
perturbing ergosterol-rich lipid rafts. Thismechanismof action is shared
with edelfosine, a compound that, like lactoferrin, exhibits anticancer
activity [35,42,46] and a marked activity against yeast [6,46]. Indeed, it
Fig. 5. Effect of bLf on Pma1p activity of wild type and rvs161Δ, erg6Δ, lac1Δ and isc1Δ mutant strains. (A) Pma1p proton pumping activity was assessed by measuring glucose-induced
external pH variation with a pH electrode. BY4741 wild type cells were incubated for 90 min in 10 mM Tris-HCl, pH 7.4 with 0–1500 μg/ml bLf or 100 μM DES. After pH stabilization,
2.5 mM glucose was added to induce proton extrusion by Pma1p and pH values were monitored up to 12 min. Data are pH values normalized to the value at timepoint zero min.
(B) Localization of bLf-FITC (fluorescein-5-isothiocyanate) (500 μg/ml) in the wild type cells 75 min after incubation in the same conditions as in A. A control with only FITC was
performed under the same conditions to ensure a specific labelling. Bar: 5 μm (C) Same as in A but with wild type and indicated mutant strains treated with 0, 425 or 850 μg/ml bLf or
100 μM DES. Values are expressed as the pH variation per min per mg of dry weight of four independent experiments. (D) ATPase activity of isolated plasma membranes of the
indicated strains expressed as percentage in comparison with the control of each strain of three independent experiments. Membranes were treated for 15 min in the absence or in
the presence of 100 μg/ml bLf or 100 μM DES in 10 mM Tris-HCl, pH 7.4 buffer supplemented with 0.2 mM (NH4)2MoO4, 5 mM NaN3, and 50 mM KNO3 to inhibit acid phosphatase,
mitochondrial and vacuolar ATPases, respectively. (E) Measurement of intracellular ATP levels of cells incubated for 90 min with 0, 250 or 425 μg/ml bLf or 100 μM DES. Values
represent the increase in ATP level expressed in fold change in comparison with the control of each strain of three independent experiments. ns, non-significant; *, **, ***, ****,
P < 0.05, 0.01, 0.001, 0.0001, respectively, in comparison with the control of each strain. (F) Representative Western blot of the immunoprecipitation between bLf and Pma1p in bLf-
treated wild type and mutant strains. (G) Quantification of Pma1p/bLf ratio in relation to the wild type strain in the immunoprecipitates. Values represent the mean of three
independent experiments.
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Fig. 6. Pma1p localization, expression levels and proton pumping activity of wild type and rvs161Δ, erg6Δ, lac1Δ and isc1Δmutant strains. (A) Cells transformed with pRS316 PMA1-GFP
plasmidwere stainedwith 0.1mg/mlfilipin and visualizedunder afluorescencemicroscopewith green (PMA1-GFP) and blue (filipin) channels. DIC images are also shown and images are
representative of each condition. Bar: 7.5 μm. (B) Representative Western blot image of endogenous Pma1p expression levels in each strain. Pgk1p was used as loading control.
(C) Quantification of Pma1p expression levels normalized to Pgk1p levels. Values represent the mean of three independent experiments. (D) Pma1p proton pumping activity was
assessed by measuring glucose-induced external pH variation using a pH electrode. After pH stabilization, 2.5 mM glucose was added to induce proton extrusion by Pma1p and pH
values were monitored up to 12 min. Values are expressed as the pH variation per min per mg of dry weight of four independent experiments. Values represent the mean of four
independent experiments. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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and induces loss of Pma1p from lipid rafts [46].Mr, Interestingly, the bLf
effect on lipid rafts differs from MβCD, which is known to disrupt lipid
rafts by depleting ergosterol from the plasma membrane [37]. Actually,
while both compounds led to intracellular accumulation of ergosterol,
in contrast to MβCD, bLf-treated cells still preserved ergosterol staining
at the plasma membrane, as visualized by the intracellular and plasma
membrane filipin staining. This suggests that bLf impairs the sorting of
newly synthetized ergosterol to the lipid rafts of the cell surface, rather
than sequestering it from the plasma membrane.
In order to gain insights on the importance of lipid rafts integrity for
bLf antifungal activity, a comprehensive characterization of the pheno-
type of mutant strains lacking the lipid rafts-associated proteins
Rvs161p, Erg6p, Lac1p or Isc1p was performed. Ergosterol plays crucial
roles in bulk membrane functions and in lipid rafts formation as it is es-
sential for membrane fluidity/rigidity, permeability and for the protein
sorting along the secretory pathway [47,48]. In erg6Δmutants, the accu-
mulated ergosterol precursors do not allow a tight packing of the lipid
bilayer, specifically the lipid acyl chains, and are suggested to create
voids in the plasma membrane [47]. Accumulation of ergosterol352intermediates can also alter lipid rafts structures, promote missorting
of different plasmamembrane proteins [49] andmodifymembrane per-
meability and fluidity [50]. Sphingolipids are a multifunctional class of
lipids critical for lipid rafts formation and for many other functions in-
cluding the transport of glycosylphosphatidylinositol (GPI)-anchored
proteins out of the endoplasmic reticulum, protein sorting and signal-
ling [51]. In yeast, ceramides can be produced either de novo through
Lag1p/Lac1p/Lip1p, or from complex sphingolipids hydrolysis through
Isc1p [25]. LAC1 and LAG1 are highly homologous and have a similar
function; along with a small accessory subunit Lip1p, Lac1p and Lag1p
are demonstrated constituents of the ceramide synthase complex [52].
Deletion of both genes influences the levels of ceramides and long
chain bases [52,53]. Yeast cells lacking Lac1p show an abnormal low
amount of GPI-anchored proteins and impaired capacity to link the cer-
amide moiety into GPI anchors, which are very important for the asso-
ciation of different proteins to lipid rafts [53,54]. In turn, isc1Δ cells
contain higher amount of complex sphingolipids [55], decreased levels
of mitochondrial ceramide andmitochondrial function defects [56]. An-
other mutant studied herein lacks the Rvs161 protein, a lipid rafts com-
ponent involved in cytoskeleton organization, cell polarity, endocytosis
Fig. 7. Effect of bLf onV-ATPase and vacuolar pH. (A) Representativefluorescencemicroscopy images of BY4741wild type cells incubated in the absence (control) or presence of 425 μg/ml
bLf for 90 min at 30 °C in Tris-HCl 10 mM pH 7.4 and then stained with CDCFDA. White arrows indicate cells with increased vacuolar fluorescence. Bar: 7.5 μm. (B) Quantification of the
greenmedian fluorescence intensity of BY4741wild type and rvs161Δ, erg6Δ, lac1Δ and isc1Δmutant strains treated in the same conditionswithout andwith 250 or 425 μg/ml bLf. Values
aremedian of three independent experiments normalized to T0 and control of each strain. ** P<0.01 in comparisonwith the control of each strain; #, #### P<0.05; 0.0001, respectively,
in comparison with the same condition in the wild type strain. (C) Kinetics of ATP-dependent V-ATPase proton pumping activity of vacuoles isolated from the wild type BY 4741 strain
before (control) and after addition of 4 and 80 μg/ml bLf. The continuous lines are derived by fitting the data points to a Michäelis–Menten kinetics. Vacuolar suspensions were
previously stained with the pH-sensitive probe ACMA and analysed by spectrofluorimetry after addition of increasing concentrations of ATP. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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thought to be mediated by a putative raft-bound protein as it has no
GPI signal anchor or transmembrane domain [23]. We found that cells
lacking Rvs161p, Lac1p, Isc1p and Erg6p are more resistant to bLf-
induced cell death than the wild type strain and exhibited a lower inhi-
bition of the extracellular acidification rate and Pma1p hydrolytic activ-
ity, as well as no enhancement of the intracellular ATP level. Moreover,
while 500 μg/ml bLf induced a drastic loss of cell viability in the erg6Δ
and rvs161Δmutants similarly to the wild type, their metabolic activity
was not affected in contrast to the wild type. Indeed, these two mutant
strains, as well as isc1Δ and lac1Δ were still able to process the FUN-1
dye and form CIVS when incubated with 425 μg/ml bLf, which induces
a similar percentage of cell viability as 500 μg/ml bLf in the wild type
(Fig. 2A). These results suggest that normal levels of ergosterol,
sphingolipids and lipid rafts-associated proteins determine the bLf kill-
ing activity against yeast but not its effect on metabolic activity.
We hypothesized that changes in Pma1p localization, expression
and activity in the mutant strains could explain the reduced cytotoxic
effects of bLf in the mutant strains. However, this hypothesis was
discarded as Pma1p localization and levels of expression and activity353of themutantswere identical to those of thewild type strain. The results
regarding the erg6Δ mutant are in agreement with previous works
showing that Pma1p localization at the plasma membrane was intact
in different ergmutants [58,59], and that the extracellularmedium acid-
ification kinetics in the erg24Δ mutant was identical to the wild type
strain [60]. Moreover, it was shown that deletion of ISC1 in Cryptococcus
neoformans did not affect the synthesis and transport of Pma1p [61],
which is in agreement with our data. Unexpectedly, the inhibition of
Pma1p activity by bLf was not associated with lack of Pma1p-bLf bind-
ing since this was not abrogated in the mutant strains. In addition, bLf
was unable to perturb the ergosterol-rich lipid rafts distribution in the
mutant strains, indicating that this bLf-induced alteration is also depen-
dent on the normal composition of lipid rafts. Altogether this suggests
that the perturbation of lipid rafts is intimately related with Pma1p in-
hibition, and both effects seem to depend on each other.
Evidence supporting the hypothesis that bLf requires the integrity of
Pma1p-lipid rafts association to inhibit Pma1p and induce yeast cell
death was provided by the experiments with the strain harbouring
Pma1p point mutations and with the ast1Δ strain. Pma1–10 mutation
renders a defective association of Pma1p with the lipid rafts at 37 °C
Fig. 8. Effect of bLf on cell survival of strains with defective association of Pma1p with lipid rafts or lacking Ast1p. (A) L3852 wild type and Pma1–10 (XGY32) expressing cells were
cultivated at 30 °C until OD640 = 0.7 and then transferred to 37 °C in the absence or presence of 75 μg/ml bLf in 10 mM Tris HCl pH 7.4, for 90 min. Control cells were kept at 30 °C.
Values are percentage of cell survival assuming the control without bLf as 100% cell survival. (B) BY4741 wild type, ast1Δ and ast1Δ + pAC49 AST1 strains treated with 50 to 125 μg/
ml bLf in 10 mM Tris HCl buffer pH 7.4 for 90 min at 30 °C. Values are percentages normalized to the control without bLf of each strain (considered as 100% cell survival). **, ***
P < 0.01, 0.001, respectively, in comparison with the wild type strain in the same condition. (C) ast1Δ cells expressing pRS316 PMA1-GFP were grown until exponential phase and
visualized under a fluorescence microscope for observation of Pma1p localization. (D) Percentage of ast1Δ cells with altered Pma1p localization. The individual percentual values of
each observed field as well as the mean and standard deviation are presented. More than 800 cells were counted. (E) ast1Δ cells expressing pRS316 PMA1-GFP were grown in the
same conditions as in C and D. For lipid rafts visualization, cells were stained in the dark with 0.1 mg/ml filipin immediately before visualization under the microscope. Right images
are the zoom in with higher exposure of the indicated sections of the whole images. Bars: 4.5 μm or 3 μm, as indicated in the figure.
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bLf than the wild type strain. At a permissive temperature, where
Pma1–10 is associatedwith the lipid rafts, the sensitivity to bLfwas sim-
ilar to the wild type cells. In addition, deletion of the AST1 gene that en-
codes a protein involved in Pma1p association with the lipid rafts [17],
rendered yeast cells resistant to bLf, and its overexpression in the dele-
tion background restored the sensitivity to bLf. The Pma1p and lipid354rafts distribution are affected in the ast1Δ strain, further supporting
that the alteration of Pma1p-lipid rafts association underlies the bLf-
resistance phenotype of this strain.
Besides being involved in the association of Pma1p with lipid rafts,
Ast1p was also demonstrated to induce Pma1p oligomerization, which
is an early event during the surface delivery of Pma1p [17]. Pma1p
forms large oligomeric complexes of about 1 MDa [18] and this process
C. Santos-Pereira, M.T. Andrés, S.R. Chaves et al. International Journal of Biological Macromolecules 171 (2021) 343–357seems to be affected by alterations in the sphingolipids synthesis. In-
deed, deletion of ISC1 in C. neoformans perturbed Pma1p oligomeriza-
tion, which was restored after supplementation with phytoceramide
[61]. Depletion of sphingolipids either by using the lcb1–100 strain,
which is unable to synthetize sphingolipids, or myriocin, an inhibitor
of serine palmitoyltransferase activity, inhibits the oligomerization of
newly synthetized Pma1p. Addition of the ceramide precursor
phytosphingosine restored Pma1p oligomerization, reinforcing the im-
portance of sphingolipid levels for Pma1p oligomerization [18]. Accord-
ingly, the requirement of sphingolipids for Pma1p oligomerization at
the ER, plasma membrane targeting, stability and acquisition of deter-
gent resistance of Pma1p has been reported by different authors
[19,58]. In agreement with these data, herein we found that exogenous
addition of C2-ceramide reverts the resistance phenotype of the lac1Δ
mutant strain to bLf, likely by counteracting defects in Pma1p oligomer-
ization as a result of sphingolipids composition reestablishment
(Fig. S1). Hence, the most likely explanation for the mutant's resistance
phenotypes is that alterations in the lipidic content of cells, namely un-
balanced ceramide/complex sphingolipids ratio, accumulation of ergos-
terol precursors, or the abnormal production of GPI anchors modifies
the composition of plasma membrane lipid rafts, affecting Pma1p con-
formation and oligomerization, and consequently its inhibition by bLf.
Accordingly, it has been suggested that perturbation of the lipid rafts
functional organization creates a different biophysical environment
that may change the conformation of raft-localized proteins, including
Pma1p [62].Fig. 9.Workingmodel of themode of action underlying bovine lactoferrin antifungal activity. Ex
extracellular acidification rate and consequent enhancement of intracellular proton accumulati
purified vacuoles or indirectly through intracellular acidification [63], leading to vacuolar alkalin
disrupting ergosterol-rich lipid rafts. Oligomerization of Pma1p is suggested to occur at the ER
plasma membrane delivery [17]. This evidence, together with our data, led to the hypothe
(extracelular pH), pHvac (vacuolar pH), ER (endoplasmic reticulum).
355Another novelty of the present study regards the inhibition of the V-
ATPase by bLf. The observed inhibition of this proton pump in purified
vacuoles from thewild type strain correlatedwell with the observed in-
crease of the vacuolar pH in whole cells in response to bLf. As for the
strains with altered lipid rafts composition, the vacuolar pH was not af-
fected most likely due to the inability of bLf to inhibit Pma1p and cause
intracellular acidification. Nonetheless, a possible alteration of the vacu-
olar membrane lipid compositionmay also account for the apparent in-
capacity of bLf to inhibit V-ATPase in these strains. These results are in
accordance with our previous data showing that bLf increases the lyso-
somal pH of highly metastatic cancer cells [42] and inhibits the activity
of the V-ATPase that is targeted to the plasmamembrane of highlymet-
astatic cancer cells, as well as the activity of purified rat liver lysosomes
V-ATPase [35].
5. Conclusion
The results gathered in this study demonstrate that the mode of ac-
tion underlying bLf antifungal activity lies on the perturbation of lipid
rafts organization and inhibition of Pma1p activity, and likely of V-
ATPase activity, as suggested by our data with whole cells and isolated
vacuoles (Fig. 9). Moreover, the composition of the plasma membrane
lipid rafts, Pma1p oligomerization status, as well as the integrity of
Ast1p-mediated lipid rafts-Pma1p association seems to be crucial for
the interaction of bLf with Pma1p, and for its killing activity against
S. cerevisiae. We propose that this novel bLf lipid rafts disrupting activityposure of yeast cells to bLf leads to inhibition of Pma1p, associatedwith an inhibition of the
on and ATP concentration. In addition, bLf may directly inhibit V-ATPase as observed with
isation.Moreover, bLf binds to Pma1p and induces intracellular accumulation of ergosterol
[64] and the involvement of Ast1p in the process seems to be an early event during Pma1p
sis that Pma1p oligomerization is important for bLf-mediated Pma1p inhibition. pHext
C. Santos-Pereira, M.T. Andrés, S.R. Chaves et al. International Journal of Biological Macromolecules 171 (2021) 343–357may be explored towards antifungal therapy alone or in combination
with classical antifungals.
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